Shared decision-making should therefore integrate patient priorities regarding weight reduction, treatment tolerability, cost, timing of conception, and readiness for OI or ART, rather than relying on body weight alone as the sole marker of success
Therefore, models which are metabolically competent and can be used to profile metabolism alongside toxicity can be expected to be of particular value
A commenter expressed concern about the 65-day timeline for patients to respond to the survey
Semaglutide is administered as a once-weekly subcutaneous injection (a small needle just under the skin most patients say they barely feel it)
If youre considering weight loss solutions, we encourage you to take our quiz and discover the best personalized treatment for your needs
[PubMed] [Google Scholar] Hsieh M